We’re excited to announce that Berkeley Lights and IsoPlexis are moving forward together as PhenomeX, a premier functional cell biology company. Visit Site

Back to Webinars
Proteomics
Sharpening a Double-Edged Sword: Bispecific CAR-T Cancer Therapies

Featured Speaker: David Miklos, MD, PhD, Chief Clinical Director, Blood and Marrow Transplantation and Cellular Therapy, Cancer Cell Therapy Stanford University

Your data is secure

We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this Webinar we discuss:

CAR-T benefits are T cell dependent

Treatment schema for CAR-T cell therapy

Explore several case studies

Explore Related Resources

Access related webinars, eBooks, app notes & case studies.

Blog
CAR-T Leader Makes Strides in the Bispecifics Space: See What’s Next for Functional Single-Cell Proteomics
E-Book
Expert Roundtable: Leaps in Innovation in Cancer Immunology
E-Book
Roundtable on Advances in Cell & Immunotherapies in Treating Cancer
awards-bar-3-wide-color-right
awards-bar-4-wide-color-left
Watch the Webinar
Back to the Top